Jayme Dahlin
Medical Director, Clinical Development, Oruka Therapeutics
Jayme Dahlin is listed as Medical Director, Clinical Development, Oruka Therapeutics. Jayme is scheduled to speak at SLAS 2027 International Conference & Exhibition on 30 January 2027.
Compiled from published conference agendas; not yet confirmed by Jayme. Is this you? Claim this profile.
About
Jayme L. Dahlin, M.D., Ph.D., is a Medical Director in Clinical Development at Oruka Therapeutics. Prior to his joining Oruka Therapeutics, he was Associate Director in Translational Medicine at Agios Pharmaceuticals, where he contributed to the clinical development and regulatory approvals of mitapivat (AQVESME) for adults with transfusion-dependent and non-transfusion-dependent alpha and beta thalassemia. After earning his M.D. and Ph.D. from the Mayo Clinic, he completed a clinical residency in clinical pathology at Brigham and Women’s Hospital/Harvard Medical School and a postdoctoral fellowship in chemical biology at the Broad Institute in the laboratories of Drs. Stuart L. Schreiber and Bridget K. Wagner. He served as a consultant in translational medicine and chemical biology at the National Center for Advancing Translational Sciences (NCATS) before transitioning to industry. Dr. Dahlin is board-certified in clinical pathology from the American Board of Pathology, and currently
Upcoming
SLAS 2027 International Conference & Exhibition 30 January 2027 – 3 February 2027
- Assay Guidance Workshop for High-Throughput Screening and Lead Discovery Speaker · 30 January 2027
Spoke alongside
People who have shared a session with Jayme at events on B2DB.
- Benjamin Bader Director / Head of Screening · Nuvisan 1 shared session
- Joe Trask Life Sciences Segment Manager, NA · Revvity 1 shared session
- Michelle Arkin Professor, Pharm Chem; co-Director, Small Molecule Discovery Center · University of California - San Francisco 1 shared session
- Nathan Coussens Scientific Director, Molecular Pharmacology Laboratory · Frederick National Laboratory for Cancer Research 1 shared session
- Sarine Markossian Editor-in-Chief, Assay Guidance Manual (AGM) and Lead, AGM Translational Science Resources Program · NCATS/NIH 1 shared session
- Stefan Grotegut Executive Director, High-Throughput Screening · Eli Lilly and Company 1 shared session
- Terry Riss Scientific Ambassador · Promega Corporation 1 shared session
- Thomas D.Y. Chung Director, Translational Programs Outreach · Sanford Burnham Prebys Medical Discovery Institute 1 shared session